Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Further genetic testing would show that Sophie has one of a group of rare conditions called CODE (congenital diarrhea and enteropathies) that disrupts the function of cells in the intestine, causing ...

Sanofi said that its Rilzabrutinib treatment was granted orphan drug designation, which is used in the U.S. by the Food and Drug Administration. The designation is a status assigned to a medicine ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...

After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...

Biomarker testing also extends beyond cancer care. The science is being used in the treatment of other diseases including ...

AI helped Thomas Wagner understand Alexander disease, find connection with other conditions and discover researchers who ...

Initial pediatric subject shows sustained benefit with QRX003; second patient approved for full-body treatment in ongoing ...

CHICAGO (WLS) -- A case of tuberculosis was reported in a north suburban high school. The Lake County Health department said ...

The first known case of alien hand syndrome was reported by German neurologist Kurt Goldstein in 1908. AHS is sometimes ...

The supplemental New Drug Application for the C3G and IC-MPGN indications is supported by data from the phase 3 VALIANT study.